There is that, but the market at this point will reward sales and sales growth I believe, so JB’s stock management approach I brlive will hurt forward projections.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025